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Summary
Objective: Examine effects of insulin-like growth factor 1 (IGF1), transforming growth factor b2 (TGFb2) and ﬁbroblast growth factor 2 (FGF2)
on proteoglycan and collagen network and biomechanical properties of the newly formed cartilage matrix.
Methods: Bovine articular chondrocytes were cultured in alginate beads for 3 weeks with or without FGF2, TGFb2 or IGF1 in the presence of
10% FCS. Proteoglycan content, collagen content, hydroxylysylpyridinoline cross-links and overall matrix metalloproteinase (MMP) activity in
the culture medium were measured. Alginate disks cultured for 5 weeks were used to evaluate the effect of growth factors on mechanical
properties of the construct by determining the equilibrium aggregate modulus and secant modulus.
Results: IGF1 increased collagen and proteoglycan deposition. FGF2 mainly decreased collagen deposition and TGFb2 proteoglycan depo-
sition. A decrease in cross-links was observed in matrix produced by chondrocytes cultured in the presence of TGFb2. IGF1 and FGF2 had no
inﬂuence on the number of cross-links per collagen molecule. Overall MMP activity was signiﬁcantly higher in culture medium of cells cultured
with FGF2. TGFb2 and IGF1 had no effect on MMP activity. After 35 days of culture, the matrix produced under inﬂuence of IGF1 had a lower
permeability and a trend to increase stiffness. FGF2 showed a trend to lower both properties. TGFb2 had no effect on these parameters.
Conclusion: IGF1, TGFb2 and FGF2 had differential effects on collagen network formation. Of the three growth factors tested, IGF1 seems to
be best in promoting the formation of a functional collagen network since it increased proteoglycan and collagen deposition and improved the
mechanical properties.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Once damaged, adult articular cartilage has a poor repair
capacity, which is probably due to the ineffective repair of
the collagen network, since proteoglycan depletion is often
reversible1. Although collagen turnover is increased in oste-
oarthritis, this does not lead to the formation of a functional
network2e7. A similar phenomenon is seen in cartilage tis-
sue engineering both in vitro and in vivo, where proteogly-
cans are abundantly produced but the amount of collagen
produced is limited, probably impairing functional properties
of the newly formed matrix8.
Type II collagen belongs to the ﬁbril-forming collagens
and accounts for more than 90% of the collagenous
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Received 8 November 2005; revision accepted 4 April 2006.1protein in adult articular cartilage, where it deﬁnes the ba-
sic architecture and provides tensile strength9,10. Together
with type IX and XI, collagen type II forms ﬁbrils11,12, which
are stabilized by the formation of intermolecular pyridino-
line cross-links. In cartilage, collagen molecules are cross-
linked via the hydroxyallysine route, which is mediated
by enzymes such as (telopeptidyl) lysyl hydroxylases
(TLH, LH) and lysyl oxidase13, resulting in lysylpyridinoline
(LP) or hydroxylysylpyridinoline (HP)14,15. HP and LP are
chemical variants of a mature trifunctional collagen cross-
link16, both giving strength to the cartilage. In cartilage,
HP is found at 30- to 50-fold higher levels than LP.
In healthy cartilage, the extracellular matrix is continu-
ously remodeled although slowly: this is a balance between
enzymatic degradation of matrix components and de novo
synthesis by chondrocytes. One group of matrix degrading
enzymes is the matrix metalloproteinases (MMP) family.
Members of the MMP family are capable of degrading prac-
tically all components of the extracellular matrix including
collagen and aggrecan in their substrates17. A variety of
cells including chondrocytes secrete MMPs and their pro-
duction can be inﬂuenced by several factors including
growth factors18.136
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inﬂuenced by growth factors. In previous studies, growth
factors have demonstrated to inﬂuence proteoglycan pro-
duction and deposition. In culture, insulin-like growth factor
1 (IGF1) stimulates proteoglycan production in a dose-
dependent manner19. Fibroblast growth factor 2 (FGF2)
has pleiotropic effects: both stimulation and inhibition of pro-
teoglycan deposition have been described, depending on
the FGF-2 concentration20, but also on the presence or ab-
sence of fetal calf serum21 or the employed cell culture sys-
tem (monolayer versus alginate)21,22. Transforming growth
factor b2 (TGFb2) also has variable effects when used in
in vitro studies; while a dose-dependent inhibition of proteo-
glycan production is observed, a stimulation has also been
described, depending on the culture conditions19,23.
While most studies focus on proteoglycan metabolism,
we are interested in the effects of growth factors on the
functional quality of the matrix and therefore choose colla-
gen as our main focus in this study. Speciﬁcally, we inves-
tigated the amount of collagen and proteoglycan synthesized,
the number of collagen cross-links formed and the mechan-
ical properties of the formed matrix as a consequence of
IGF1, TGFb2 and FGF2 addition to bovine chondrocytes.
Materials and methods
CELL CULTURE
Articular cartilage was harvested from the metacarpopha-
langeal joints of calves aged 6e12 months. To isolate chon-
drocytes, full-thickness slices of noncalciﬁed articular
cartilage were subjected to pronase (2 mg/ml, Sigma,
St. Louis, MO, USA) digestion for 2 h followed by overnight
collagenase B (1.5 mg/ml, Roche Diagnostics) digestion.
The chondrocytes were resuspended in 1.2% (w/v) low vis-
cosity alginate (Keltone) in 0.9% NaCl (Sigma) at a concen-
tration of 4 106 cells/ml and beads were made as
described previously24,25. Brieﬂy, the cell-alginate suspen-
sion was pressed through a 22-gauge needle in 105 mM
CaCl2. Beads were washed with 0.9% NaCl and Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM)/F12 (GibcoBRL, Gai-
thersburg, MD, USA) and inspected visually. Beads that
appeared smaller or larger were not included in the
experiment. After transfer to a six-well plate (BD Falcon,
Bedford, MA, USA) they were cultured in 75 ml/bead
DMEM/F12 supplemented with 10% fetal bovine serum
(GibcoBRL), 50 mg/ml L-asorbic acid 2-phosphate (Sigma),
50 mg/ml gentamicin and 1.5 mg/ml fungizone (both Gib-
coBRL). Cells were cultured with and without 2.5 ng/ml or
25 ng/ml FGF2 (Serotex, Oxford, UK), TGFb2 (recombinant
human, R&D systems, Abington, UK) or IGF1 (Sigma) and
harvested after 11, 20 and 35 days of culture. Growth fac-
tors and their concentrations were chosen based on previ-
ous results19,26,27. Part of the cell containing beads was
used immediately for RNA extraction; the rest was stored
at 20(C until further biochemical analyses.
BIOCHEMICAL ASSAYS
Alginate beads were digested overnight at 56(C in
papain buffer (200 mg/ml papain in 50 mM ethylene diami-
netetraacetate (EDTA) and 5 mM L-cystein). Glycosamino-
glycan (GAG) amount in the digest was quantiﬁed using
dimethylmethylene blue (DMB) assay28. The metachro-
matic reaction of GAG with DMB was monitored with a
spectrophotometer, and the ratio A540:A595 was used todetermine the amount of GAG present, using chondroitin
sulfate C (Sigma) as a standard. The amount of DNA in
each papain-digested sample was determined using
Hoechst 33258 dye28,29 with calf thymus DNA (Sigma) as
a standard.
For high-performance liquid chromatography (HPLC) of
amino acids (hydroxyproline (Hyp)) and collagen cross-
links (HP and LP), the papain digest was hydrolyzed
(108(C, 18e20 h) with 6 M HCl. The hydrolyzed samples
were dried and redissolved in 200 ml water containing
2.4 mM homoarginine (internal standard for amino acids)
(Sigma). Samples were diluted 25-fold with 50% (v/v)
acetic acid for cross-link analysis and diluted 250-fold
with 0.1 M sodium borate buffer, pH 8.0, for amino acid
analysis. Additionally, to determine Hyp, amino acids
were labeled with 9-ﬂuorenylmethyl chloroformate. Re-
versed-phase HPLC of amino acids and cross-links were
performed as described previously30,31. The quantities of
cross-links were expressed as the number of residues
per collagen molecule, assuming 300 Hyp residues per
triple helix.
IMMUNOHISTOCHEMICAL STAINING FOR COLLAGEN
TYPE I AND II
To prepare histochemical cytospins, three alginate beads
cultured for 35 days were dissolved in 55 mM sodium citrate
acid. They were ﬁxed in cold acetone and pretreated with
1% hyaluronidase (Sigma). The cytospins were incubated
with monoclonal antibodies against either type I collagen
(1:100, M28; Developmental Studies Hybridoma Bank), or
type II collagen (1:100, II-II6B3; Developmental Studies
Hybridoma Bank) at room temperature for 2 h, followed by
incubation with anti-mouse Fab-fragments conjugated with
alkaline phosphatase (GAMAP; 1:100; immunotech, Mar-
seille, France) for 30 min and mouse monoclonal alkaline
phosphatase anti-alkaline phosphatase (APAAP; 1:100;
Dakopatts, Copenhagen, Denmark; 1:100) for 30 min.
Freshly prepared neo-fuchsin substrate was used to
achieve staining.
After staining, cytospins were scored for the number of
cells positive for collagen types I and II per 100 cells in
four ﬁelds of sight per specimen, resulting in a percentage
of positive cells. An arbitrary scoring system from 1 to 5
was used, with 1 representing less than 10% of the cells
positive, 2 representing 10e40% positive, 3 representing
40e60% positive, 4 representing 60e90% positive and 5
representing more than 90% of the cells positive. A cell
was considered positive, when the matrix around the cell
or the cytoplasm was stained red.
GENE EXPRESSION ANALYSIS
For total RNA isolation, alginate beads were dissolved in
150 ml/bead 55 mM sodium citrate acid. Cell pellet was sus-
pended in 1000 ml RNA-Bee (TEL-TEST, Inc.; Friends-
wood, TX, USA) per million cells according to manufacturer’s
guidelines, and subsequently precipitated with 2-propanol
and puriﬁed with lithium chloride. Total RNA was quanti-
ﬁed using Ribogreen reagent (R-11490, Molecular
Probes Europe BV, Leiden, the Netherlands) according
to manufacturer’s instructions, and 500 ng total RNA of
each sample was reverse transcribed into complementary
DNA (cDNA) using RevertAid First Strand cDNA
Synthesis Kit (MBI Fermentas, Germany).
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and aggrecan, each cDNA sample was ampliﬁed using spe-
ciﬁc primers and speciﬁc probe (Table I, Eurogentec, Sera-
ing, Belgium). For collagen type II (COL2), MMP-1, lysyl
oxidase (LOX) and TLH, each cDNA sample was ampliﬁed
using speciﬁc primers and speciﬁc molecular beacons
(Table II, Biolegio, Nijmegen, The Netherlands). All
ampliﬁcations were done in a total reaction volume of
25 ml containing 1 Polymerase Chain Reaction (PCR)
buffer, 0.4 mM of each deoxyribonucleotide triphosphate
(dNTP), Mg2þ (3.5 mM for the molecular beacons and
5 mM for the probes), 0.5 unit of Taq polymerase (all from
Eurogentec) and each primer and probe or beacon. PCR
was performed in an ABI PRISM 7000 (Applied Biosys-
tems, Foster City, CA, USA) sequence detection system
and consisted of a 5-min interval at 95(C followed by 40
cycles of 95(C for 30 s and 60(C for 1 min for hydrolysis
probe assays and 40 cycles of 95(C for 30 s, 56(C for
40 s, and 72(C for 30 s for beacon assays. Data were ana-
lyzed using Sequence Detector version 1.7 (Applied Biosys-
tems) software and normalized for GAPDH expression and
expression in the control condition without growth factors32.
TOTAL MMP ASSAY
The culture medium was used to determine general MMP
activity as described earlier33. General MMP activity was
measured using 5 mM (all concentrations are ﬁnal) ﬂuoro-
genic substrate TNO211-F (Dabcyl-Gaba-Pro-Gln-
Gly-Leu-Cys[Fluorescein]-Ala-Lys-NH2) in the presence or
absence of 12.5 mM BB94 (a general MMP inhibitor). Me-
dium samples were diluted (ﬁnal dilution 1/2) in MMP buffer
(50 mM Tris [pH 7.5], 5 mM CaCl2, 150 mM NaCl, 1 mM
ZnCl2, 0.01% Brij-35, 0.02% NaN3) containing a general
proteinase inhibitor (Complete, EDTA free, one tablet in
12.5 ml, Roche). The MMP activity in each sample was cal-
culated as the difference in the initial rate of substrate con-
version (linear increase in ﬂuorescence in time, expressed
as relative ﬂuorescence units per second) between sam-
ples with and without BB94 addition. Fluorescence was
measured for 6 h at 30(C using a Cytoﬂuor 4000 (Applied
Biosystems, Foster City, CA, USA). This assay is consid-
ered to represent overall metalloproteinase activity.
MECHANICAL TESTING
For mechanical characterization, we used 4 106 cells/
ml in 1.2% (w/v) alginate constructs of 3 mm thick and
6 mm in diameter. The constructs were prepared as previ-
ously described by Wong et al.34 Directly after making the
cell containing alginate disks, samples were taken for me-
chanical testing at day 0, which is indicative for the mechan-
ical strength of the alginate. Constructs were mounted on
a materials testing machine (type LRX, Lloyd Instrument,
Farnham, UK) in a radially unconﬁned stress relaxation
test with the construct between impermeable platens, andhydrated in 0.9% saline with protease inhibitor Complete
(Sigma). A 20% uniaxial compressive strain was then ap-
plied within 10 s at a ramped displacement strain rate of
2% s1, based on the measured thickness. The strain was
maintained constant at this plateau for 30 min with the
load recorded at a sampling frequency of 20 Hz using
a 10 N load cell. The applied load recorded by the load
cell was divided by the cross-sectional area of the construct
to calculate the applied stress. The secant modulus was
calculated as stress/strain at 10 s, where the stress had
its peak response and the strain reached its maximum pla-
teau. At the end of the test, the equilibrium aggregate mod-
ulus was determined again as stress/strain at 30 min creep.
DATA ANALYSIS
The experiments at day 11 were repeated twice with
three samples of seven beads per experimental condition
for biochemical analysis and one sample of 10 beads per
experimental condition for gene expression analysis. The
experiments at day 20 were repeated four times with three
samples of seven beads per experimental condition for bio-
chemical analysis and one sample of 10 beads per experimen-
tal condition for gene expression analysis. The experiments
at day 35 were repeated three times with a total of 10
samples for the control, IGF1 and TGFb2 condition and
eight samples for the FGF2 condition. Overall MMP activ-
ity in the culture medium and collagen type I and II
deposition with cytospins was determined in one experi-
ment in triplicate.
Statistical analysis was performed using SPSS 11.5
(SPSS Inc. Chicago, IL) software. All data are presented
as mean standard deviation, except for the gene expres-
sion data, which are presented as boxplots with the median
and the 25th and 75th quartile. Control groups without
growth factors and groups supplemented with growth fac-
tors were compared using a KruskalleWallis H test with
a post hoc ManneWhitney U test.
Results
EFFECTS OF GROWTH FACTORS ON MATRIX DEPOSITION
AND CROSS-LINKS
To investigate the effect of different growth factors on ma-
trix deposition, we cultured chondrocytes in three-dimen-
sional alginate beads in the presence of growth factors.
The amount of DNA was determined in the alginate beads,
to give an indication of the number of chondrocytes present
in the beads. Between the experiments, the amount of DNA
at day 0 was 0.18 mg DNA/bead 0.025 mg/bead. After 20
days, the amount of DNA in the control condition was
0.27 mg/bead 0.04. In time, the used growth factors had
no signiﬁcant effect on the amount of DNA per bead com-
pared to the control condition without growth factors. Addi-
tion of IGF1 resulted in 97%, TGFb2 in 95% and FGF2 in
112% of the amount of DNA compared to the controlTable I
Sequences of primers and probes for real-time PCR
Primers Probe
GAPDH Forward: GTCAACGGATTTGGTCGTATTGGG Fam-TGGCGCCCCAACCAGCC-Tamra
Reverse: TGCCATGGGTGGAATCATATTGG
Aggrecan Forward: GGACACTCCTTGCAATTTGAGAA Fam-CCATCACCATCTTCCAGGAGCGAGA-Tamra
Reverse: CAGGGCATTGATCTCGTATCG
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Sequences of primes and beacons real-time PCR
Primers Beacon
TLH Forward: TTAAAGGAAAGACACTCCGATCAGAGATGA Fam-cgtgcgCGTGATAAACTGGATCCTGATATGGCTCTTcgcacg-Dabcyl
Reverse: AATGTTTCCGGAGTAGGGGAGTCTTTTT
LOX Forward: GTGGCCGACCCCTACTACATCC Fam-cgtgccATGCGCGGCGGAGGAAAACTGggcacg-Dabcyl
Reverse: AGCAGCACCCTGTGATCATAATCTC
MMP-1 Forward: ACCCCAGACCTGTCAAGAGCA Fam-cgtgccAAAGCCTTTCAACTCTGGAGCAATGTCACggcacg-Dabcyl
Reverse: TCCCCTGACAAAGGATATCATTATcondition at day 20. Because the used growth factors had
no differential effects on the cell proliferation and we were
interested in the overall matrix production, not in the matrix
production per cell, results of matrix deposition are ex-
pressed per alginate bead.
Chondrocytes in alginate produced considerable
amounts of proteoglycans over the 3-week culture period,
resulting in a proteoglycan concentration in the control con-
dition of 8.1 mg/bead at day 11 and 29.9 mg/bead at day 20.
Cultured in the presence of 25 ng/ml IGF1, the chondro-
cytes deposited more proteoglycans than in the control con-
dition resulting in 1.4-fold increase of proteoglycans at day
11 and 1.8-fold increase of proteoglycans at day 20 (Fig. 1).
2.5 ng/ml IGF1 resulted in more proteoglycans at day 20 but
not at an earlier time point. Addition of TGFb2 to the culture
medium of chondrocytes resulted in less proteoglycans at
both time points, although the effect was not signiﬁcant
with 25 ng/ml TGFb2 at day 20. Cells stimulated with
2.5 ng/ml FGF2 deposited more proteoglycans at both
time points whereas 25 ng/ml FGF2 had no signiﬁcant
effect on the deposition (Fig. 1).
The effect of growth factors on collagen, the other main
constituent of cartilage, was also investigated in our study.
Chondrocytes in alginate beads produced 4.8 mg collagen/
bead at day 11 and 8.3 mg collagen/bead at day 20. Addi-
tion of IGF1 resulted in approximately the same effect as
that seen on proteoglycan deposition; 1.6-times more colla-
gen at day 11 and 1.8-times more collagen at day 20 with
25 ng/ml IGF1. With 2.5 ng/ml IGF1 the upregulation was
only signiﬁcant at day 20. At day 11, TGFb2 had no effect
on collagen deposition but by day 20, both concentrations
resulted in 25% less collagen. FGF2 had a bidirectional ef-
fect on collagen deposition; 2.5 ng/ml FGF2 resulted inmore collagen deposition, although this was not signiﬁcant
at day 20; whereas 25 ng/ml resulted in less collagen depo-
sition, up to a 1.75-fold downregulation at day 20 (Fig. 2).
After 20 days of culture, HP cross-links were present in
the collagen network in contrast with LP cross-links, which
were almost undetectable in the extracellular matrix. During
the 20 days of culture, IGF1 and FGF2 had no signiﬁcant
effect on the HP cross-links. On the other hand, the use
of 2.5 or 25 ng/ml TGFb2, unexpectedly downregulated
HP cross-links per collagen molecule 2.5 times and 3.1
times, respectively (Fig. 3).
TYPE OF COLLAGEN PRODUCTION
To conﬁrm whether the appropriate type of collagen (col-
lagen type II) is made in our alginate system, a immunos-
taining for collagen type I and type II was performed on
cytospins at the end of the experiment after 35 days of cul-
ture. Sixty to 90% of the cells cultured in the presence of
25 ng/ml IGF1 [Fig. 4(A)] and TGFb2 [Fig. 4(B)] were posi-
tive for collagen type II , in contrast to the control and the
FGF2 condition where approximately 40e60% of the cells
were positive for collagen type II [Fig. 4(C and D)]. In every
condition, approximately 10e40% of the cells stained posi-
tive for collagen type I of which a representative example is
shown in Fig. 4(E).
GENE EXPRESSION OF MATRIX CONSTITUENTS AND
COLLAGEN MODIFYING ENZYMES
To examine early regulation in matrix deposition and col-
lagen cross-linking, gene expression of COL2, aggrecan,
LOX and TLH was determined after 11 and 20 days ofDay 11 Day 20
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Fig. 1. Effect of growth factors on proteoglycan deposition in three-dimensional chondrocyte cultures. Proteoglycan deposition is shown after
(A) 11 days of culture (n¼ 6) and (B) 20 days of culture (n¼ 12). *Indicates P< 0.01 and # indicates P< 0.05 compared to the control con-
dition without growth factors, which is set at 100% (SD¼ 8.2% at day 11 and SD¼ 6.8% at day 20). Data are presented as mean %SD.
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Fig. 2. Effect of growth factors on collagen deposition in three-dimensional chondrocyte cultures. Collagen deposition is shown after (A) 11
days of culture (n¼ 6) and (B) 20 days of culture (n¼ 12). *Indicates P< 0.01 and # indicates P< 0.05 compared to the control condition
without growth factors, which is set at 100% (SD¼ 2.5% at day 11 and SD¼ 16.1% at day 20). Data are presented as mean %SD.culture. COL2 expression was not inﬂuenced by 25 ng/ml
IGF1 at both time points [Fig. 5(A)]. Furthermore, there
was almost no effect of IGF1 on aggrecan, LOX and TLH
expression at day 11 [Fig. 5(BeD)]. At day 20, on the other
hand, aggrecan expression is 2.7 times upregulated com-
pared to that of control [Fig. 5(B)].
Expression of the matrix constituents collagen type II and
aggrecan was considerably downregulated when cells were
cultured in the presence of TGFb2 for 11 days [Fig. 5(A and
B)], in contrast to the culture after 20 days where TGFb
hardly had an effect on COL2 and aggrecan expression.
In contrast to the expectations, 25 ng/ml TGFb2 had no ap-
parent effect on the enzymes LOX and TLH involved in col-
lagen cross-linking during the culture period [Fig. 5(C and
D)].
Twenty-ﬁve ng/ml FGF2 downregulated COL2 expres-
sion up to 23 times at day 20 [Fig. 5(A)] and had little or
no effect on aggrecan expression. The expression of the
collagen cross-linking enzymes TLH and LOX was also
downregulated in the presence of FGF2.
MMP ACTIVITY AND GENE EXPRESSION
Because MMPs inﬂuence matrix quality and content, we
determined overall MMP activity in the culture media and
gene expression for the speciﬁc collagenase MMP-1 at
control
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Fig. 3. Effect of growth factors on collagen cross-linking. HP cross-
links in newly formed collagen are shown after 20 days of culture
(n¼ 12). *Indicates P< 0.01. Data are presented as meanSD.day 20. Because we were interested in possible breakdown
of collagen type II, we did not analyze the MMP-2 expres-
sion since this is a gelatinase, which can only cleave
unwound collagen, following initial cleavage by a collage-
nase. MMP-8 and MMP-13 were not examined because
of their minor role in normal chondrocytes. 25 ng/ml IGF1
and TGFb had no signiﬁcant effect on the MMP activity in
the culture medium at day 20 compared to the control. On
the other hand, 25 ng/ml FGF2 increased the overall MMP
activity [Fig. 6(A)]. Gene expression at day 11 and day 20
of MMP-1, the most important collagenase in healthy carti-
lage, was downregulated when chondrocytes were cultured
with IGF1 and even more with TGFb2, up to 20 times less at
day 11. FGF2 had no effect on MMP-1 expression at both
day 11 and day 20 [Fig. 6(B)].
ASSOCIATION BETWEEN BIOCHEMICAL AND BIOMECHANICAL
PROPERTIES
To test whether the growth factors could inﬂuence
mechanical properties via their effect on amount of extracel-
lular matrix, its composition and cross-linking, we examined
the effect of the three growth factors on the equilibrium ag-
gregate modulus and the secant modulus. Direct after
making the cell containing alginate disks, the mechanical
properties indicated by the equilibrium aggregate modulus
and the secant modulus were 0.36 kPa and 2.1 kPa,
respectively, in concordance to previous results35. After 5
weeks of culture, matrix production contributed to the
mechanical properties, indicated by the increase of the
equilibrium aggregate modulus to 1.5 kPa and the secant
modulus to 7.0 kPa in the control condition.
Cultures with IGF1 resulted in an upregulation of the se-
cant modulus and a trend to upregulation of the equilibrium
aggregate modulus. The proteoglycan and collagen content
[Fig. 7(C and D)] in these mechanically tested constructs
was also higher than in the control condition without growth
factors. The number of cross-links per collagen molecule
[Fig. 7(E)] was equal compared to those of the control.
When chondrocytes were cultured in the presence of
TGFb2 for 5 weeks, both mechanical properties were unaf-
fected compared to the control [Fig. 7(A and B)], while the
proteoglycan deposition and the number of cross-links per
collagen molecule were greatly reduced in the same algi-
nate disks [Fig. 7(C and E)]. After 5 weeks of culture with
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Fig. 4. Immunohistochemical analysis of produced matrix. Collagen type II deposition in (A) cells cultured in the presence of IGF1; (B) TGFb2 ;
(C) FGF2 ; (D) cells cultured without growth factors; (E) collagen type I is mainly only present in large cell clusters, not in matrix of single cells;
(F) is the isotype control. Magniﬁcation is 100, with a 400 inset. Positive cells are indicated arrows, arrowheads indicate negative cells.
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75th quartile for the gene expression with the control condition without growth factors set at 1.
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Fig. 7. Relation between mechanical properties and matrix constituents after 35 days. Biochemical and biomechanical properties of tested
alginate disks after 35 days of culture as percentage compared to the control with (A) the equilibrium modulus of the newly formed matrix
(control is 100 26%), (B) the secant modulus of the newly formed matrix (control is 100 23%), (C) proteoglycan deposition (control is
100 11%), (D) collagen deposition (control is 100 12%) and (E) HP cross-links per collagen molecule (control is 100 10%). *Indicates
P< 0.01 and # indicates P< 0.05 compared to control. Data are presented as meanSD.TGFb2, collagen deposition was unaffected [Fig. 7(D)].
FGF2, on the other hand, resulted in decreased mechanical
properties, although not signiﬁcant compared to the control
[Fig. 7(A and B)]. These poor properties can partially be ex-
plained by the downregulation of collagen deposition, which
is signiﬁcant after 11 and 20 days of culture (Fig. 2), and
also appears to be downregulated but not signiﬁcant at
day 35. This is apparently not compensated by more pro-
teoglycans [Fig. 7(C)] or an equal number of cross-links
per collagen molecule [Fig. 7(E)].
Discussion
The formation of cartilage matrix in vitro or after dam-
age in vivo is characterized by low collagen production
and high proteoglycan production1,8. The present study
shows differential effects of IGF1, FGF2 and TGFb2 on
proteoglycan and collagen synthesis, collagen cross-linksand the mechanical properties of the newly formed matrix.
Of these three growth factors, IGF1 is most promising
with regard to promoting a functional extracellular matrix
with high proteoglycan and collagen deposition without al-
tering the relative number of cross-links per collagen.
Moreover, the mechanical properties of constructs cul-
tured with IGF1 were improved compared to control
constructs.
Using IGF1 in the alginate culture system resulted in ap-
proximately a 1.5-fold increase in both proteoglycan and
collagen deposition after 35 days of culture. Upregulation
of proteoglycan deposition with IGF1 is consistent with pre-
vious data19,20,26,36,37. The effect of partially blocking IGF1
previously described, which led to a reduction in proteogly-
can production38, further supports the importance of IGF1 in
proteoglycan synthesis. On the other hand, the effect on
collagen deposition in the presence of IGF1 was less
intensively investigated and less consistent. IGF1 did not
affect collagen deposition in one study36 but caused an
1144 Y. M. Jenniskens et al.: Growth factors and cartilage repairupregulation of collagen synthesis in other studies20,39. In
contrast to the increase in collagen protein that we ob-
served, gene expression of collagen type II was not
inﬂuenced whereas aggrecan expression was slightly upre-
gulated in the presence of IGF1. This suggests that many of
the synthesized collagen might be incorporated in the ma-
trix. Also, the signiﬁcant downregulation of MMP-1 expres-
sion might have contributed to more matrix deposition.
MMP activity is regulated on several levels; transcription,
translation, activation and inhibition. Therefore, the amount
of MMP-1 mRNA is only indicative for the MMP-1 activity.
The substrate used in our activity assay is mainly degraded
by other MMPs than MMP-1, possibly explaining the dis-
crepancy between the overall activity assay and the
MMP-1 gene expression data.
The quality of the cartilage matrix is determined not only
by the amount of matrix produced, but also by the number
of cross-links between collagen molecules. We therefore
determined the number of HP and LP cross-links, the two
chemical variants of the mature collagen cross-links found
in cartilage. In adult cartilage, the average is 1.5 HP
cross-links per collagen molecule40, in immature cartilage
the number is 0.8 HP. After 35 days of culture, a small al-
though not signiﬁcant increase in number of HP cross-links
per collagen molecule was detectable in the presence of
IGF1 compared in the control condition, approaching the
physiological number of cross-links in immature cartilage.
The expression of the collagen cross-linking enzymes
TLH and LOX was not inﬂuenced by the presence of
IGF1 even though more collagen was present in this culture
condition. To our knowledge, there are no other publications
about the effect of growth factors on collagen cross-linking
in cartilage.
For the adequate repair of articular cartilage defects, it is
especially important that the deposited matrix constituents
are able to resist load in an articular joint. Different types
of collagen have different properties concerning cross-link-
ing and mechanical behavior. Therefore, we determined
whether the appropriate type of collagen (collagen type II
and not collagen type I) was produced in our culture sys-
tem. Collagen type II was the most abundant type in the
newly formed matrix in the IGF1 and TGFb2 conditions.
Twenty percent of the newly formed matrix was positive
for collagen type I, which was most probably deposited by
cells in the outer layer of the alginate bead as shown
previously24.
Increased matrix deposition and increased cross-links
per collagen molecule are expected to result in improved
mechanical properties. In this study, these mechanical
properties are measured as the equilibrium aggregate mod-
ulus and the secant modulus. The secant modulus is an in-
dication for the friction between the solid and the liquid
phase (e.g., the ability to hold water), while the equilibrium
aggregate modulus is an indication for the stiffness of the
formed matrix. The increase in extracellular matrix produc-
tion in reaction to IGF1 might have resulted in a signiﬁcantly
higher secant modulus. This increased secant modulus
indicates more friction between the water and the matrix
resulting from a more condense or low permeable matrix.
The equilibrium aggregate modulus also appears to be im-
proved, although not signiﬁcantly, indicating a stiffer solid
phase. This property is deﬁned mainly by the amount of col-
lagen and relative number of collagen cross-links in the ma-
trix41, which also explains our result: more collagen
deposition and the appropriate number of cross-links per
collagen molecule. In addition, downregulation of MMP-1
gene expression might have resulted in less collagenbreakdown, contributing to better mechanical properties, al-
though this does not have to be in direct relation to each
other since one MMP can digest several matrix molecules.
Findings on the equilibrium modulus are consistent with the
study by Mauck et al.37, although this group found no result
of IGF1 on the secant modulus.
With up to 25% less collagen and proteoglycan deposi-
tion, TGFb2 had less prominent, but signiﬁcant effects on
matrix deposition. Decreased proteoglycan deposition is
consistent with previous data19,42. However, upregulation
of proteoglycan and collagen deposition using TGFb is
also shown by some authors23,36,37,42,43. Factors that might
explain these varying results in literature include different
isoforms of TGFb (TGFb1 vs TGFb2), the difference in car-
tilage donor (human, rabbit or bovine), the amount of matrix
surrounding the cell, the presence of serum in the culture or
the scaffold used for culture (polyglycolic acid, agarose or
alginate). In concordance to the inhibition of collagen and
proteoglycan deposition, gene expression at day 11 of col-
lagen type II and aggrecan was decreased compared to the
control condition but recovered at day 20. Although the im-
munostaining for collagen type II is used to determine the
type of collagen produced, it is striking to see more positive
cells in the TGFb2 condition than in the control condition,
which is in contrast to less collagen deposition in the
TGFb2 condition. Possibly, TGFb2 had a positive effect
on the type of collagen produced but not on the amount
of collagen produced. The downregulation of MMP-1 gene
expression had no effect on collagen deposition. Surpris-
ingly, we found that TGFb2 resulted in more than a
two-fold downregulation of HP cross-links per collagen
molecule. This is in contrast to what we previously found
after addition of either isoform of TGFb to ﬁbroblasts44,
this addition resulted in an almost four-fold increase of the
cross-linking enzyme LH 2b expression and more HP and
LP cross-links. In the present study, no effect was seen
on TLH gene expression. Whether this discrepancy may
be explained by different cell types or a different type of col-
lagen produced (collagen type II by chondrocytes vs colla-
gen type I by ﬁbroblasts) is currently under investigation.
The mechanical properties in cultures with TGFb2 did not
differ from the control condition, which is unexpected re-
garding the low number of collagen cross-links, the downre-
gulation of MMP-1 gene expression and in contrast to the
previous study by Mauck et al.37. It appears that, in our sys-
tem, collagen and proteoglycan amount have more effect
on mechanical properties than collagen cross-links. More-
over, in a previous study we have found that addition of
TGFb2 changed the distribution of proteoglycan over
‘‘cell-associated’’ (pericellular and territorial) and further-
removed (interterritorial) matrix in the alginate bead; rela-
tively more of the proteoglycan was laid down in the
further-removed matrix compared to the cell-associated
matrix23. Since the interterritorial matrix mainly contributes
to the mechanical properties of the construct, this might
be a mechanism to retain functional properties, indepen-
dently of the relative number of cross-links and the absolute
amount of matrix components.
FGF2 had an interesting effect on matrix deposition. Pro-
teoglycan deposition could be upregulated by FGF2, colla-
gen deposition on the other hand, was slightly increased
with the low concentration of FGF2 and reduced with the
high concentrations FGF2. This so called bidirectional effect
is described by others for proteoglycan deposition, but not
for collagen deposition20, and it cannot be completely
excluded that this results from the use of 25 ng/ml
FGF2, a concentration which could be beyond the optimal
1145Osteoarthritis and Cartilage Vol. 14, No. 11concentration for stimulating matrix deposition in this culture
system. In concordance with our results, the group of Shida
et al.45 found a decrease in mRNA levels for a1(II) procolla-
gen when FGF2 was injected in rat knee joints. When chon-
drocytes are cultured in alginate disks for 35 days with the
addition of 25 ng/ml FGF2, the proteoglycan deposition is
increased and collagen deposition is decreased but not sig-
niﬁcantly different from the control, indicating a difference in
FGF2 effect depending on the culture environment (bead vs
disc) or time of culture (3 vs 5 weeks). Immunohistological
analysis of the produced matrix in presence of FGF2, con-
ﬁrms the low collagen deposition during the culture while
only 40% of the cells were positive for collagen type II
and even less cells for collagen type I. Less collagen depo-
sition can be partially explained by the high overall MMP ac-
tivity. Collagen cross-linking levels were not inﬂuenced by
either the different concentrations of FGF2 or time, although
TLH and LOX mRNA levels were downregulated. This is not
surprising as less collagen needs to be cross-linked in this
situation. Looking at the mechanical properties, both the
equilibrium aggregate modulus and the secant modulus ap-
pear to be lower than in the control condition without growth
factors. The decrease in collagen deposition might have
resulted in a softer and also more permeable matrix indi-
cated by both the lower equilibrium aggregate and secant
modulus.
In summary, this study demonstrates differential effects
of IGF1, TGFb2 and FGF2 on generation of new cartilage.
It indicates that the use of IGF1 in culturing chondrocytes
is useful in promoting collagen synthesis and improving
mechanical properties of newly formed cartilage, whereas
TGFb2 and FGF2 do not clearly enhance these parameters.
Future studies will further investigate the quality of the pro-
duced matrix by examining the degradability of the matrix
and the organization on a nanohistological (electron micro-
scopic) level. Eventually, this may contribute to the optimal-
ization of culture conditions in cartilage tissue engineering
and might be applied in in vivo studies for the repair of artic-
ular cartilage defects.
References
1. Lafeber FP, van Roy H, Wilbrink B, Huber-Bruning O,
Bijlsma JW. Human osteoarthritic cartilage is synthet-
ically more active but in culture less vital than normal
cartilage. J Rheumatol 1992;19:123e9.
2. Aigner T, Bertling W, Stoss H, Weseloh G, von der
Mark K. Independent expression of ﬁbril-forming colla-
gens I, II, and III in chondrocytes of human osteoar-
thritic cartilage. J Clin Invest 1993;91:829e37.
3. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A,
Bourne R, Rorabeck C, et al. Enhanced cleavage of
type II collagen by collagenases in osteoarthritic artic-
ular cartilage. J Clin Invest 1997;99:1534e45.
4. Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I,
Ionescu M, et al. Evidence for altered synthesis of
type II collagen in patients with osteoarthritis. J Clin In-
vest 1998;102:2115e25.
5. Pullig O, Weseloh G, Swoboda B. Expression of type VI
collagen in normal and osteoarthritic human cartilage.
Osteoarthritis Cartilage 1999;7:191e202.
6. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN,
Lyons TJ, et al. Effect of collagen turnover on the ac-
cumulation of advanced glycation end products. J Biol
Chem 2000;275:39027e31.7. von der Mark K, Kirsch T, Nerlich A, Kuss A, Weseloh G,
Gluckert K, et al. Type X collagen synthesis in human
osteoarthritic cartilage. Indication of chondrocyte hy-
pertrophy. Arthritis Rheum 1992;35:806e11.
8. Marijnissen WJ, van Osch GJ, Aigner J, Verwoerd-
Verhoef HL, Verhaar JA. Tissue-engineered cartilage
using serially passaged articular chondrocytes. Chon-
drocytes in alginate, combined in vivo with a synthetic
(E210) or biologic biodegradable carrier (DBM).
Biomaterials 2000;21:571e80.
9. Eyre DR. Collagens and cartilage matrix homeostasis.
Clin Orthop 2004;S118e22.
10. Eyre DR. The collagens of articular cartilage. Semin
Arthritis Rheum 1991;21:2e11.
11. Blaschke UK, Eikenberry EF, Hulmes DJ, Galla HJ,
Bruckner P. Collagen XI nucleates self-assembly
and limits lateral growth of cartilage ﬁbrils. J Biol
Chem 2000;275:10370e8.
12. Hagg R, Bruckner P, Hedbom E. Cartilage ﬁbrils of
mammals are biochemically heterogeneous: differen-
tial distribution of decorin and collagen IX. J Cell Biol
1998;142:285e94.
13. van der Slot AJ, Zuurmond AM, Bardoel AF,
Wijmenga C, Pruijs HE, Sillence DO, et al. Identiﬁca-
tion of PLOD2 as telopeptide lysyl hydroxylase, an im-
portant enzyme in ﬁbrosis. J Biol Chem 2003;278:
40967e72.
14. Eyre DR, Dickson IR, Van Ness K. Collagen cross-link-
ing in human bone and articular cartilage. Age-related
changes in the content of mature hydroxypyridinium
residues. Biochem J 1988;252:495e500.
15. Reiser K, McCormick RJ, Rucker RB. Enzymatic and
nonenzymatic cross-linking of collagen and elastin.
FASEB J 1992;6:2439e49.
16. Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen
and elastin. Annu Rev Biochem 1984;53:717e48.
17. Birkedal-Hansen H. Proteolytic remodeling of extracel-
lular matrix. Curr Opin Cell Biol 1995;7:728e35.
18. Tchetina EV, Squires G, Poole AR. Increased type II col-
lagen degradation and very early focal cartilage degen-
eration is associated with upregulation of chondrocyte
differentiation related genes in early human articular
cartilage lesions. J Rheumatol 2005;32:876e86.
19. van Susante JL, Buma P, van Beuningen HM, van
den Berg WB, Veth RP. Responsiveness of bovine
chondrocytes to growth factors in medium with differ-
ent serum concentrations. J Orthop Res 2000;18:
68e77.
20. Sah RL, Chen AC, Grodzinsky AJ, Trippel SB. Differen-
tial effects of bFGF and IGF-I on matrix metabolism in
calf and adult bovine cartilage explants. Arch Biochem
Biophys 1994;308:137e47.
21. Richmon JD, Sage AB, Shelton E, Schumacher BL,
Sah RL, Watson D. Effect of growth factors on cell pro-
liferation, matrix deposition, and morphology of human
nasal septal chondrocytes cultured in monolayer.
Laryngoscope 2005;115:1553e60.
22. Loeser RF, Chubinskaya S, Pacione C, Im HJ. Basic ﬁ-
broblast growth factor inhibits the anabolic activity of
insulin-like growth factor 1 and osteogenic protein 1
in adult human articular chondrocytes. Arthritis Rheum
2005;52:3910e7.
23. van Osch GJ, van der Veen SW, Buma P, Verwoerd-
Verhoef HL. Effect of transforming growth factor-beta
on proteoglycan synthesis by chondrocytes in relation
to differentiation stage and the presence of pericellular
matrix. Matrix Biol 1998;17:413e24.
1146 Y. M. Jenniskens et al.: Growth factors and cartilage repair24. Hauselmann HJ, Fernandes RJ, Mok SS, Schmid TM,
Block JA, Aydelotte MB, et al. Phenotypic stability of
bovine articular chondrocytes after long-term culture
in alginate beads. J Cell Sci 1994;107(Pt 1):17e27.
25. Loeser RF, Carlson CS, McGee MP. Expression of
beta 1 integrins by cultured articular chondrocytes
and in osteoarthritic cartilage. Exp Cell Res 1995;
217:248e57.
26. De Mattei M, Pellati A, Pasello M, Ongaro A, Setti S,
Massari L, et al. Effects of physical stimulation with
electromagnetic ﬁeld and insulin growth factor-I
treatment on proteoglycan synthesis of bovine artic-
ular cartilage. Osteoarthritis Cartilage 2004;12:
793e800.
27. Veilleux N, Spector M. Effects of FGF-2 and IGF-1 on
adult canine articular chondrocytes in type II collage-
neglycosaminoglycan scaffolds in vitro. Osteoarthritis
Cartilage 2005;13:278e86.
28. Farndale RW, Buttle DJ, Barrett AJ. Improved quantita-
tion and discrimination of sulphated glycosaminogly-
cans by use of dimethylmethylene blue. Biochim
Biophys Acta 1986;883:173e7.
29. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluoromet-
ric assay of DNA in cartilage explants using Hoechst
33258. Anal Biochem 1988;174:168e76.
30. Bank RA, Jansen EJ, Beekman B, te Koppele JM.
Amino acid analysis by reverse-phase high-perfor-
mance liquid chromatography: improved derivatization
and detection conditions with 9-ﬂuorenylmethyl chloro-
formate. Anal Biochem 1996;240:167e76.
31. Bank RA, Beekman B, Verzijl N, de Roos JA,
Sakkee AN, TeKoppele JM. Sensitive ﬂuorimetric
quantitation of pyridinium and pentosidine crosslinks
in biological samples in a single high-performance liq-
uid chromatographic run. J Chromatogr B Biomed Sci
Appl 1997;703:37e44.
32. Livak KJ, Schmittgen TD. Analysis of relative gene ex-
pression data using real-time quantitative PCR and
the 2(Delta Delta C(T)) method. Methods 2001;25:
402e8.
33. DeGroot J, Verzijl N, Wenting-Van Wijk MJ, Bank RA,
Lafeber FP, Bijlsma JW, et al. Age-related decrease
in susceptibility of human articular cartilage to matrix
metalloproteinase-mediated degradation: the role of
advanced glycation end products. Arthritis Rheum
2001;44:2562e71.
34. Wong M, Siegrist M, Wang X, Hunziker E. Development
of mechanically stable alginate/chondrocyte con-
structs: effects of guluronic acid content and matrix
synthesis. J Orthop Res 2001;19:493e9.35. Knight MM, van de Breevaart Bravenboer J, Lee DA,
van Osch GJ, Weinans H, Bader DL. Cell and nucleus
deformation in compressed chondrocyte-alginate con-
structs: temporal changes and calculation of cell mod-
ulus. Biochim Biophys Acta 2002;1570:1e8.
36. Blunk T, Sieminski AL, Gooch KJ, Courter DL,
Hollander AP, Nahir AM, et al. Differential effects of
growth factors on tissue-engineered cartilage. Tissue
Eng 2002;8:73e84.
37. Mauck RL, Nicoll SB, Seyhan SL, Ateshian GA,
Hung CT. Synergistic action of growth factors and dy-
namic loading for articular cartilage tissue engineering.
Tissue Eng 2003;9:597e611.
38. Schalkwijk J, Joosten LA, van den Berg WB, van
Wyk JJ, van de Putte LB. Insulin-like growth factor
stimulation of chondrocyte proteoglycan synthesis by
human synovial ﬂuid. Arthritis Rheum 1989;32:66e71.
39. Tuncel M, Halici M, Canoz O, Yildirim Turk C, Oner M,
Ozturk F, et al. Role of insulin like growth factor-I in re-
pair response in immature cartilage. Knee 2005;12:
113e9.
40. Bank RA, Bayliss MT, Lafeber FP, Maroudas A,
Tekoppele JM. Ageing and zonal variation in post-
translational modiﬁcation of collagen in normal human
articular cartilage. The age-related increase in non-
enzymatic glycation affects biomechanical properties
of cartilage. Biochem J 1998;330(Pt 1):345e51.
41. Mow VC, Holmes MH, Lai WM. Fluid transport and me-
chanical properties of articular cartilage: a review. J Bi-
omech 1984;17:377e94.
42. Frazer A, Bunning RA, Thavarajah M, Seid JM,
Russell RG. Studies on type II collagen and aggrecan
production in human articular chondrocytes in vitro
and effects of transforming growth factor-beta and
interleukin-1beta. Osteoarthritis Cartilage 1994;2:
235e45.
43. van Osch GJ, van den Berg WB, Hunziker EB,
Hauselmann HJ. Differential effects of IGF-1 and
TGF beta-2 on the assembly of proteoglycans in peri-
cellular and territorial matrix by cultured bovine articular
chondrocytes. Osteoarthritis Cartilage 1998;6:187e95.
44. van der Slot-Verhoeven A, van Dura E, de Wit E,
DeGroot J, Huizinga TWJ, Bank RA, et al. Elevated
formation of pyridinoline crosslinks by proﬁbrotic cyto-
kines is associated with enhanced lysyl oxidase 2b
levels. Biochim Biophys Acta 2005;95e102.
45. Shida J, Jingushi S, Izumi T, Iwaki A, Sugioka Y. Basic
ﬁbroblast growth factor stimulates articular cartilage
enlargement in young rats in vivo. J Orthop Res
1996;14:265e72.
